Patents by Inventor Robert T. Schooley

Robert T. Schooley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIVIRAL PRODRUGS, PHARMACEUTICAL FORMULATIONS, AND METHODS
    Publication number: 20230287029
    Abstract: Compounds, including antiviral prodrugs, and pharmaceutical formulations including the compounds, which may be orally bioavailable or formulated for intramuscular injection. Methods for producing compounds, such as antiviral prodrugs. Methods for treating coronavirus and other RNA virus infection in mammals. Methods of producing a drug triphosphate.
    Type: Application
    Filed: July 24, 2021
    Publication date: September 14, 2023
    Inventors: Karl Y. Hostetler, James Beadle, Nadejda Valiaeva, Robert T. Schooley
  • SUBSTITUTION MONOTHERAPY TREATMENT FOR HIV-1 INFECTION EMPLOYING ANTIBODY PRO140
    Publication number: 20200385475
    Abstract: This invention relates to the use of antibody therapy as a treatment substitute, or for treatment interruption, to treat HIV-1 infected patients. Specifically, the present invention relates to the use of antibody therapy, such as PRO 140 monoclonal antibody therapy, as a monotherapy for treatment of HIV-1 infected patients.
    Type: Application
    Filed: January 8, 2020
    Publication date: December 10, 2020
    Inventors: Robert T. Schooley, Nader Z. Pourhassen
  • Substitution monotherapy treatment for HIV-1 infection employing antibody PRO140
    Patent number: 10562969
    Abstract: This invention relates to the use of antibody therapy as a treatment substitute, or for treatment interruption, to treat HIV-1 infected patients. Specifically, the present invention relates to the use of antibody therapy, such as PRO 140 monoclonal anti-body therapy, as a monotherapy for treatment of HIV-1 infected patients.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: February 18, 2020
    Assignee: Cytodyn Inc.
    Inventors: Robert T. Schooley, Nader Z. Pourhassen
  • HIV ANTIBODY THERAPY AS TREATMENT SUBSTITUTE
    Publication number: 20170335002
    Abstract: This invention relates to the use of antibody therapy as a treatment substitute, or for treatment interruption, to treat HIV-1 infected patients. Specifically, the present invention relates to the use of antibody therapy, such as PRO 140 monoclonal anti-body therapy, as a monotherapy for treatment of HIV-1 infected patients.
    Type: Application
    Filed: August 20, 2015
    Publication date: November 23, 2017
    Applicant: CYTODYN INC.
    Inventors: Robert T. Schooley, Nader Z. Pourhassen